Literature DB >> 8771227

Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder.

R L Trestman1, R S Keefe, V Mitropoulou, P D Harvey, M L deVegvar, S Lees-Roitman, M Davidson, A Aronson, J Silverman, L J Siever.   

Abstract

There is evidence that some schizophrenic patients have deficits on tests of cognitive function, particularly tests of executive function, including the Wisconsin Card Sorting Test (WCST) and the Trail-making Test, Part B. This study was conducted to determine the generalizability of these findings across the schizophrenia spectrum to schizotypal personality disorder (SPD). Forty DSM-III SPD patients, 56 nonschizophrenia-related other personality disorder (OPD) patients, and 32 normal volunteers from two medical centers performed tests of executive function such as the WCST, Trail-making Part B, Stroop Word-Color Test, and Verbal Fluency, as well as tests of more general intellectual functioning such as the Wechsler Intelligence Scale-Revised Vocabulary and Block Design subtests, and Trail-making Part A. SPD patients performed more poorly on the WCST and on Trail-making Part B than did OPD patients or normal subjects; the groups did not differ on tests of general intellectual functioning. SPD patients may share some of the cognitive deficits observed in schizophrenia.

Entities:  

Mesh:

Year:  1995        PMID: 8771227     DOI: 10.1016/0165-1781(95)02709-2

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  21 in total

1.  Smaller left Heschl's gyrus volume in patients with schizotypal personality disorder.

Authors:  Chandlee C Dickey; Robert W McCarley; Martina M Voglmaier; Melissa Frumin; Margaret A Niznikiewicz; Yoshio Hirayasu; Stephanie Fraone; Larry J Seidman; Martha E Shenton
Journal:  Am J Psychiatry       Date:  2002-09       Impact factor: 18.112

Review 2.  Oxytocin and social cognition in affective and psychotic disorders.

Authors:  M Mercedes Perez-Rodriguez; Katie Mahon; Manuela Russo; Allison K Ungar; Katherine E Burdick
Journal:  Eur Neuropsychopharmacol       Date:  2014-08-01       Impact factor: 4.600

3.  Fronto-temporal disconnectivity in schizotypal personality disorder: a diffusion tensor imaging study.

Authors:  Motoaki Nakamura; Robert W McCarley; Marek Kubicki; Chandlee C Dickey; Margaret A Niznikiewicz; Martina M Voglmaier; Larry J Seidman; Stephan E Maier; Carl-Fredrik Westin; Ron Kikinis; Martha E Shenton
Journal:  Biol Psychiatry       Date:  2005-06-22       Impact factor: 13.382

Review 4.  How does studying schizotypal personality disorder inform us about the prodrome of schizophrenia?

Authors:  Katherine Seeber; Kristin S Cadenhead
Journal:  Curr Psychiatry Rep       Date:  2005-03       Impact factor: 5.285

Review 5.  The brain in schizotypal personality disorder: a review of structural MRI and CT findings.

Authors:  Chandlee C Dickey; Robert W McCarley; Martha E Shenton
Journal:  Harv Rev Psychiatry       Date:  2002 Jan-Feb       Impact factor: 3.732

6.  Factors in sensory processing of prosody in schizotypal personality disorder: an fMRI experiment.

Authors:  Chandlee C Dickey; Istvan A Morocz; Daniel Minney; Margaret A Niznikiewicz; Martina M Voglmaier; Lawrence P Panych; Usman Khan; Rayna Zacks; Douglas P Terry; Martha E Shenton; Robert W McCarley
Journal:  Schizophr Res       Date:  2010-04-01       Impact factor: 4.939

7.  MRI abnormalities of the hippocampus and cavum septi pellucidi in females with schizotypal personality disorder.

Authors:  Chandlee C Dickey; Robert W McCarley; Mina L Xu; Larry J Seidman; Martina M Voglmaier; Margaret A Niznikiewicz; Erin Connor; Martha E Shenton
Journal:  Schizophr Res       Date:  2006-10-05       Impact factor: 4.939

8.  Cognitive deficits in psychiatric disorders: Current status.

Authors:  J K Trivedi
Journal:  Indian J Psychiatry       Date:  2006-01       Impact factor: 1.759

9.  Processing sentence context in women with schizotypal personality disorder: an ERP study.

Authors:  Margaret A Niznikiewicz; Michelle Friedman; Martha E Shenton; Martina Voglmaier; Paul G Nestor; Melissa Frumin; Larry Seidman; John Sutton; Robert W McCarley
Journal:  Psychophysiology       Date:  2004-05       Impact factor: 4.016

Review 10.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Authors:  Patricia S Goldman-Rakic; Stacy A Castner; Torgny H Svensson; Larry J Siever; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.